Biweekly Docetaxel and S-1 combination chemotherapy as first-line treatment for elderly patients with advanced gastric cancer

This study assessed the toxicity and activity of biweekly docetaxel and S-1 combination therapy in elderly patients with advanced gastric cancer. One-hundred and thirteen patients were enrolled: 35 were 75 years old or more. The objective response rate, toxicity, progression-free survival (PFS), and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anticancer research 2013-02, Vol.33 (2), p.697-704
Hauptverfasser:	Kunisaki, Chikara, Takahashi, Masazumi, Ono, Hidetaka A, Hasegawa, Shinichi, Tsuchida, Kazuhito, Oshima, Takashi, Ota, Mitsuyoshi, Fukushima, Tadao, Tokuhisa, Motohiko, Izumisawa, Yusuke, Takagawa, Ryo, Kimura, Jun, Kosaka, Takashi, Makino, Hirochika, Akiyama, Hirotoshi, Endo, Itaru
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - mortality Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Disease-Free Survival Drug Combinations Female Humans Kaplan-Meier Estimate Male Middle Aged Oxonic Acid - administration & dosage Oxonic Acid - adverse effects Proportional Hazards Models Stomach Neoplasms - drug therapy Stomach Neoplasms - mortality Taxoids - administration & dosage Taxoids - adverse effects Tegafur - administration & dosage Tegafur - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!